Cargando…

ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma

BACKGROUND: Cancer cells display widespread changes in DNA methylation that may lead to genetic instability by global hypomethylation and aberrant silencing of tumor suppressor genes by focal hypermethylation. In turn, altered DNA methylation patterns have been used to identify putative tumor suppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Götze, Silke, Feldhaus, Valeska, Traska, Thilo, Wolter, Marietta, Reifenberger, Guido, Tannapfel, Andrea, Kuhnen, Cornelius, Martin, Dirk, Müller, Oliver, Sievers, Sonja
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804712/ https://www.ncbi.nlm.nih.gov/pubmed/20017917 http://dx.doi.org/10.1186/1471-2407-9-447

Ejemplares similares

ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer
por: Tang, Gao-Yan, et al.
Publicado: (2019)

Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion
por: Li, Wei, et al.
Publicado: (2010)

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2011)

The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma
por: Li, Linwei, et al.
Publicado: (2010)

A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma
por: Li, Lin-wei, et al.
Publicado: (2011)

Retraction: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma
por: Li, Linwei, et al.
Publicado: (2011)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas
por: Wolter, Marietta, et al.
Publicado: (2022)

ECRG-4 expression in normal and neoplastic choroid plexus
por: Donahue, John E, et al.
Publicado: (2010)

Ecrg4 peptide is the ligand of multiple scavenger receptors
por: Moriguchi, Tetsuo, et al.
Publicado: (2018)

Downregulation and DNA methylation of ECRG4 in gastric cancer
por: Deng, Peng, et al.
Publicado: (2018)

Loss of Ecrg4 improves calcium oxalate nephropathy
por: Cabuzu, Daniela, et al.
Publicado: (2022)

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
por: Wang, Shumin, et al.
Publicado: (2010)

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma
por: Tong, Joanna H, et al.
Publicado: (2010)

Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma
por: Xiao, Xue, et al.
Publicado: (2013)

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
por: Codo, Paula, et al.
Publicado: (2014)

Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis
por: Qian, Sangni, et al.
Publicado: (2022)

Ecrg4 Attenuates the Inflammatory Proliferative Response of Mucosal Epithelial Cells to Infection
por: Kurabi, Arwa, et al.
Publicado: (2013)

Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells
por: SONG, HAI-YAN, et al.
Publicado: (2014)

ECRG4 Expression in Normal Rat Tissues: Expression Study and Literature Review
por: Porzionato, A., et al.
Publicado: (2015)

A potential link between aberrant expression of ECRG4 and atrial fibrillation
por: Zhang, Zuojing, et al.
Publicado: (2023)

Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas
por: Rothhammer-Hampl, Tanja, et al.
Publicado: (2021)

Hypermethylation of HIC2 is a potential prognostic biomarker and tumor suppressor of glioma based on bioinformatics analysis and experiments
por: Luo, Feifei, et al.
Publicado: (2023)

Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation
por: Tao, Yan-Fang, et al.
Publicado: (2014)

Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer
por: Buchegger, Kurt, et al.
Publicado: (2017)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
por: Lázcoz, Paula, et al.
Publicado: (2006)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
por: Bae, Min Gyun, et al.
Publicado: (2016)

Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma
por: Ito, Yuki, et al.
Publicado: (2023)

Aberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer
por: Wang, Hao, et al.
Publicado: (2016)

Frequent Epigenetic Suppression of Tumor Suppressor Gene Glutathione Peroxidase 3 by Promoter Hypermethylation and Its Clinical Implication in Clear Cell Renal Cell Carcinoma
por: Liu, Qianling, et al.
Publicado: (2015)

ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo
por: XU, TING, et al.
Publicado: (2013)

ECRG4 regulates neutrophil recruitment and CD44 expression during the inflammatory response to injury
por: Dorschner, Robert A., et al.
Publicado: (2020)

Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas
por: Zhang, Zuping, et al.
Publicado: (2008)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer
por: De Faveri, L E, et al.
Publicado: (2013)

Promoter Hypermethylation of Tumour Suppressor Genes as Potential Biomarkers in Colorectal Cancer
por: Ng, Jennifer Mun-Kar, et al.
Publicado: (2015)

Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma
por: Morris, Mark R., et al.
Publicado: (2010)

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
por: Truong, M, et al.
Publicado: (2012)

PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance
por: Zhang, Cheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7lpmuvl0s48h5n3vvatumurnm0